Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial

Lancet
Holger ThieleGerhard Schuler

Abstract

Intracoronary administration of an abciximab bolus during a primary percutaneous coronary intervention results in a high local drug concentration, improved perfusion, and reduction of infarct size compared with intravenous bolus application. However, the safety and efficacy of intracoronary versus standard intravenous bolus application in patients with ST-elevation myocardial infarction (STEMI) undergoing this intervention has not been tested in a large-scale clinical trial. The AIDA STEMI trial was a randomised, open-label, multicentre trial. Patients presenting with STEMI in the previous 12 h with no contraindications for abciximab were randomly assigned in a 1:1 ratio by a central web-based randomisation system to intracoronary versus intravenous abciximab bolus (0·25 mg/kg bodyweight) during percutaneous coronary intervention with a subsequent 12 h intravenous infusion 0·125 μg/kg per min (maximum 10 μg/min). The primary endpoint was a composite of all-cause mortality, recurrent infarction, or new congestive heart failure within 90 days of randomisation. Secondary endpoints were the time to occurrence of the primary endpoint, each individual component of that endpoint, early ST-segment resolution, thrombolysis in myocardial...Continue Reading

References

Jan 5, 1985·British Medical Journal·S J Pocock
May 4, 1985·British Medical Journal·B M Rifkind
Jun 2, 2004·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Francesco BellandiRoberto Piero Dabizzi
Feb 21, 2006·Lancet·UNKNOWN Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) inv
Nov 6, 2007·The New England Journal of Medicine·Stephen D WiviottUNKNOWN TRITON-TIMI 38 Investigators
May 24, 2008·The New England Journal of Medicine·Gregg W StoneUNKNOWN HORIZONS-AMI Trial Investigators
Aug 19, 2008·Lancet·Arnoud W J Van't HofUNKNOWN Ongoing Tirofiban In Myocardial infarction Evaluation (On-TIME) 2 study group
Jul 18, 2009·Journal of the American College of Cardiology·Giampaolo NiccoliFilippo Crea
Jul 17, 2010·Journal of the American College of Cardiology·Matthew T RoeJohn S Rumsfeld
Jun 2, 2011·Platelets·Marek KozinskiJacek Kubica

❮ Previous
Next ❯

Citations

Oct 18, 2012·Journal of Thrombosis and Thrombolysis·Henry E SpeichLisa K Jennings
Aug 28, 2012·European Heart Journal·UNKNOWN Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)Doron Zahger
Jan 4, 2013·European Heart Journal·Nick E J West
Nov 23, 2012·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Salvatore GeraciCorrado Tamburino
Feb 25, 2014·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Sorin J BrenerGregg W Stone
Apr 1, 2014·Current Atherosclerosis Reports·Petko Prodanov, Petr Widimsky
Mar 29, 2014·Current Treatment Options in Cardiovascular Medicine·Vikas Singh, Mauricio G Cohen
Jan 4, 2013·European Heart Journal·Simon R Redwood
Sep 27, 2014·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Bernardo CorteseMarco Valgimigli
Feb 12, 2013·Cardiovascular Revascularization Medicine : Including Molecular Interventions·Danny DvirRon Waksman
Oct 1, 2014·Herz·D TrenkW Hochholzer
Oct 30, 2014·Future Cardiology·Leila GanjeheiAndrew Kim Saal
Aug 15, 2012·Current Opinion in Critical Care·Eric R Bates, Daniel S Menees
Jan 23, 2016·Expert Review of Cardiovascular Therapy·Sebastian Johannes ReinstadlerIngo Eitel
Jul 3, 2013·Indian Heart Journal·Vijayakumar Subban, K Sarat Chandra
Oct 20, 2012·Annales de cardiologie et d'angéiologie·G CaylaJ-P Collet
Sep 5, 2014·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Stephan WindeckerAdam Witkowski
Jan 23, 2016·Expert Opinion on Pharmacotherapy·Giuseppe GargiuloMarco Valgimigli
Oct 18, 2015·Annals of Vascular Surgery·Gregory G SalzlerAndrew J Meltzer
Mar 19, 2016·European Journal of Heart Failure·Thomas StiermaierIngo Eitel
Feb 24, 2016·Circulation Journal : Official Journal of the Japanese Circulation Society·Sebastian J ReinstadlerIngo Eitel
Oct 1, 2013·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·William B Hillegass, Brigitta C Brott
Sep 23, 2014·Journal of the American College of Cardiology·Ingo EitelHolger Thiele
Aug 9, 2015·Vascular Pharmacology·Marco ZimarinoRaffaele De Caterina
Sep 14, 2015·European Heart Journal·Giampaolo NiccoliFilippo Crea
Sep 2, 2014·European Journal of Clinical Investigation·Ville KytöPäivi Rautava
Apr 9, 2016·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Alfredo MarcheseHitoshi Yaku
Jul 16, 2015·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Ingo EitelH Thiele
Apr 22, 2015·The American Journal of Cardiology·Kevin R BaineyPaul W Armstrong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

© 2022 Meta ULC. All rights reserved